Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells.

@article{Solr2008ErythropoietinIA,
  title={Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells.},
  author={Peter Sol{\'a}r and J{\'a}n Kovaľ and Jaromir Mikes and J{\'a}n Kleban and Zuzana Sol{\'a}rov{\'a} and J{\'a}n Laz{\'u}r and Ingrid Hodorov{\'a} and Peter Fedoro{\vc}ko and Arthur J. Sytkowski},
  journal={Molecular cancer therapeutics},
  year={2008},
  volume={7 8},
  pages={2263-71}
}
Recombinant human erythropoietin is widely used to treat anemia associated with cancer and with the myelosuppressive effects of chemotherapy, particularly platinum-based regimens. Erythropoietin is the principal regulator of erythroid cell proliferation, differentiation, and apoptosis. Recently, the antiapoptotic and proliferative effects of erythropoietin on nonhematopoietic cells were also established. We now show the effect of erythropoietin treatment on the response of A2780 and SKOV3… CONTINUE READING